Cornea/External Disease

Top Story

VIDEO: Klarity-C study shows improvements in dry eye scores

January 18, 2020

Kala completes enrollment in STRIDE 3 trial

January 17, 2020
Kala Pharmaceuticals has completed enrollment in the STRIDE 3 trial for KPI-121 0.25%, a treatment for temporary dry eye relief, according to a press release. The…
Meeting News

Glaukos leverages acquisitions to enter new ophthalmology spaces

January 16, 2020
With recent acquisitions, Glaukos now has multiple products in development that expand its reach outside of the glaucoma space and into more comprehensive ophthalmology…
Meeting News

Oyster Point’s dry eye nasal spray meets phase 2 endpoints

January 15, 2020
Oyster Point Pharma’s nasal spray treatment for dry eye disease has met its primary endpoints in the phase 2 MYSTIC trial, CEO and President Jeffrey Nau
More Headlines »
Clinical Science

Epi-LASIK: A Confocal Microscopy Analysis of the Corneal Epithelium and Anterior Stroma

Ophthalmic Surgery, Lasers and Imaging Retina, July 2012, Volume 43 Issue 4
To evaluate the confocal microscopy findings at the corneal epithelium and anterior stroma after epi-LASIK. Twelve eyes…
More »

A Clearer Focus: Moving Forward to Improve the Management of Ocular Surface Disease

This activity is supported by an educational grant from Shire.

More »
Meeting News

VIDEO: Field of innovations to treat dry eye ‘exploding’

October 29, 2019
More »